Trial Profile
A Prospective, Double-blind, Randomized Placebo-controlled Trial of Carvedilol for Early Primary Prophylaxis of Esophageal Varices in Cirrhosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary)
- Indications Oesophageal varices; Portal hypertension
- Focus Therapeutic Use
- Acronyms Small_Vx
- 13 Jun 2016 Results published in the Gut
- 20 Mar 2014 New trial record